Phlorotannins: Towards New Pharmacological Interventions for Diabetes Mellitus Type 2. (Q39064669)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28042834%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

3 references

27 October 2020

4 February 2021

25 June 2021

Phlorotannins: Towards New Pharmacological Interventions for Diabetes Mellitus Type 2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28042834%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

8 references

13 March 2019

14 March 2019

24 March 2019

9 September 2019

22 October 2019

7 November 2019

16 November 2019

27 October 2020

6 references

9 September 2019

22 October 2019

7 November 2019

16 November 2019

27 October 2020

4 February 2021

1 reference

9 September 2019

1 reference

22 October 2019

1 reference

7 November 2019

macromolecular substances

1 reference

16 November 2019

anti-diabetic medication

1 reference

27 October 2020

1 reference

25 June 2021

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28042834%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Patrícia Valentão

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28042834%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

Graciliana Lopes

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28042834%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

author name string

Graciliana Lopes

series ordinal

1

1 reference

PubMed ID

28042834

8 September 2017

language of work or name

English

0 references

publication date

30 December 2016

11 references

13 March 2019

14 March 2019

24 March 2019

9 September 2019

22 October 2019

7 November 2019

16 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28042834%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

27 October 2020

4 February 2021

25 June 2021

11 references

13 March 2019

14 March 2019

24 March 2019

9 September 2019

22 October 2019

7 November 2019

16 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28042834%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

27 October 2020

4 February 2021

25 June 2021

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28042834%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28042834%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

4 April 2020

copyright license

10 references

13 March 2019

14 March 2019

24 March 2019

9 September 2019

22 October 2019

7 November 2019

16 November 2019

27 October 2020

4 February 2021

25 June 2021

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

21 January 2018

Oral Antidiabetic Agents

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes--impact on adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Bioactive compounds from macroalgae in the new millennium: implications for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Trends in the discovery of new marine natural products from invertebrates over the last two decades--where and what are we bioprospecting?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Marketed marine natural products in the pharmaceutical and cosmeceutical industries: tips for success

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Impact of ocean acidification on energy metabolism of oyster, Crassostrea gigas--changes in metabolic pathways and thermal response

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Potential Bioactive Compounds from Seaweed for Diabetes Management

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Postprandial hyperglycemia and diabetes complications: is it time to treat?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Insulin: potential negative consequences of early routine use in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Recent Advances in Synthetic Chemistry of Diabetic Research.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Oxidative stress and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Advanced glycation end products and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Preparation and chromatographic analysis of phlorotannins

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

6,6'-bieckol isolated from Ecklonia cava protects oxidative stress through inhibiting expression of ROS and proinflammatory enzymes in high-glucose-induced human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Isolation of a new phlorotannin, a potent inhibitor of carbohydrate-hydrolyzing enzymes, from the brown alga Sargassum patens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Protein tyrosine phosphatase 1B and α-glucosidase inhibitory Phlorotannins from edible brown algae, Ecklonia stolonifera and Eisenia bicyclis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Dieckol isolated from Ecklonia cava inhibits alpha-glucosidase and alpha-amylase in vitro and alleviates postprandial hyperglycemia in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Dieckol isolated from brown seaweed Ecklonia cava attenuates type ІІ diabetes in db/db mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Protective effects of dieckol isolated from Ecklonia cava against high glucose-induced oxidative stress in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

α-Glucosidase- and α-amylase-inhibitory activities of phlorotannins from Eisenia bicyclis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Diphlorethohydroxycarmalol isolated from Ishige okamurae, a brown algae, a potent alpha-glucosidase and alpha-amylase inhibitor, alleviates postprandial hyperglycemia in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Octaphlorethol A, a novel phenolic compound isolated from a brown alga, Ishige foliacea, increases glucose transporter 4-mediated glucose uptake in skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Octaphlorethol A, a novel phenolic compound isolated from Ishige foliacea, protects against streptozotocin-induced pancreatic β cell damage by reducing oxidative stress and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Octaphlorethol A: a potent α-glucosidase inhibitor isolated from Ishige foliacea shows an anti-hyperglycemic effect in mice with streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Octaphlorethol A, a marine algae product, exhibits antidiabetic effects in type 2 diabetic mice by activating AMP-activated protein kinase and upregulating the expression of glucose transporter 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Phlorofucofuroeckol A isolated from Ecklonia cava alleviates postprandial hyperglycemia in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Limitations in the use of dixon plots to evaluate enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Efficacy and safety of a dieckol-rich extract (AG-dieckol) of brown algae, Ecklonia cava, in pre-diabetic individuals: a double-blind, randomized, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Effects of brown alga, Ecklonia cava on glucose and lipid metabolism in C57BL/KsJ-db/db mice, a model of type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Phlorotannins from Alaskan seaweed inhibit carbolytic enzyme activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Hypoglycemic Effect of Sargassum ringgoldianum Extract in STZ-induced Diabetic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

The α-amylase and α-glucosidase inhibitory effects of Irish seaweed extracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Hepatoprotective effects of dieckol-rich phlorotannins from Ecklonia cava, a brown seaweed, against ethanol induced liver damage in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Novel concepts in insulin regulation of hepatic gluconeogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Aldose reductase, oxidative stress, and diabetic mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Can phlorotannins purified extracts constitute a novel pharmacological alternative for microbial infections with associated inflammatory conditions?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Retracted: Protein Tyrosine Phosphatase 1B and Insulin Resistance: Role of Endoplasmic Reticulum Stress/Reactive Oxygen Species/Nuclear Factor Kappa B Axis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Exercise, GLUT4, and skeletal muscle glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

The insulin signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Brown alga Ecklonia cava attenuates type 1 diabetes by activating AMPK and Akt signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Glucose, Advanced Glycation End Products, and Diabetes Complications: What Is New and What Works

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Increased methylglyoxal and advanced glycation end products in kidney from spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Advanced glycation end products (AGE) and diabetes: cause, effect, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Protective effect of diphlorethohydroxycarmalol isolated from Ishige okamurae against high glucose-induced-oxidative stress in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Diabetes, oxidative stress and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Antioxidant enzymes and human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Palmitate-induced apoptosis can occur through a ceramide-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

6,6'-Bieckol protects insulinoma cells against high glucose-induced glucotoxicity by reducing oxidative stress and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22010056

Ishige okamurae ameliorates hyperglycemia and insulin resistance in C57BL/KsJ-db/db mice

21 January 2018

1 reference

12 December 2020

Drug evaluation: ranirestat--an aldose reductase inhibitor for the potential treatment of diabetic complications

1 reference

12 December 2020

Thiazolidinediones: the case for early use.

1 reference

12 December 2020

Dieckol isolated from Ecklonia cava protects against high-glucose induced damage to rat insulinoma cells by reducing oxidative stress and apoptosis

1 reference

12 December 2020

Voglibose (Basen, AO-128), one of the most important alpha-glucosidase inhibitors

1 reference

12 December 2020

2. Classification and Diagnosis of Diabetes

1 reference

12 December 2020

Phlorotannins from brown algae (Fucus vesiculosus) inhibited the formation of advanced glycation endproducts by scavenging reactive carbonyls

1 reference

12 December 2020

Phlorotannins from Brown Algae: inhibition of advanced glycation end products formation in high glucose induced Caenorhabditis elegans

1 reference

12 December 2020

The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas

1 reference

12 December 2020

Marine natural products

1 reference

12 December 2020

Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin.

1 reference

12 December 2020

10.3390/MOLECULES22010056

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28042834%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28042834%20AND%20SRC:MED&resulttype=core&format=json

4 April 2020

1 reference